Global Medicines Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 9.10 M
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.23 Cr
- Revenue Growth -37.26%
- Profit Growth 56.50%
- Ebitda 75.63%
- Net Worth -18.27%
- Total Assets -19.87%
About Global Medicines
Global Medicines Limited (GML) is a Public Limited Indian Non-Government Company incorporated in India on 02 March 1994 and has a history of 30 years and 11 months. Its registered office is in Kheda, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 9.10 M.
The company currently has active open charges totaling ₹5.23 Cr.
Girishbhai Patel, Alpeshbhai Patel, and Mayurkumar Patel serve as directors at the Company.
Company Details
-
Location
Kheda, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ1994PLC021466
-
Company No.
021466
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
02 Mar 1994
-
Date of AGM
20 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Global Medicines Limited offer?
Global Medicines Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Inorganic Salts, Flavours & Aromatics, Food Additive, Fertilizers and Soil Additives, Potassic Fertilizers, Common Disease Medicines, Antihistamines, Industrial Chemicals & Supplies, Heptahydrate.
Who are the key members and board of directors at Global Medicines?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Girishbhai Patel | Director | 17-Jan-2011 | Current |
Alpeshbhai Patel | Director | 17-Jan-2011 | Current |
Mayurkumar Patel | Additional Director | 30-Sep-2024 | Current |
Financial Performance of Global Medicines.
Global Medicines Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.26% decrease. The company also saw a substantial improvement in profitability, with a 56.5% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Global Medicines?
In 2023, Global Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.23 Cr
₹0
Charges Breakdown by Lending Institutions
- Oriental Bank Of Commerce : 5.23 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
08 Jun 2012 | Oriental Bank Of Commerce | ₹2.15 Cr | Open |
10 May 2012 | Oriental Bank Of Commerce | ₹9.30 M | Open |
10 May 2012 | Oriental Bank Of Commerce | ₹2.15 Cr | Open |
How Many Employees Work at Global Medicines?
Unlock and access historical data on people associated with Global Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Global Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Global Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.